Post by
subaru1i on Aug 14, 2023 12:30pm
My personal question: What will come first, M&A activity or
the drug monograph? I ask this because we don't have to wait for a drug monograph from the FDA for ANY type of M&A, including M&A activity with their global pharma partner. With that said, anything could happen now at any time.
OH, ps: Congratulation to the LABS team on a great quarter, didn't want press *1 on the CC just to say that :-)
Comment by
okgonow on Aug 14, 2023 12:42pm
was amazed no one asked about ongoing trials, german/EU buissness, the Braziian stuff, and FDA response to the stuff sent after inspection
Comment by
subaru1 on Aug 14, 2023 1:40pm
and also why management doesn't put emphasis on that instead of waiting for question on these subject.
Comment by
Vikingstock on Aug 14, 2023 2:52pm
Where you on the call this morning? I think their direction was as good as you will get in a public co., across cost reduction, market opportunities, mergers acquisitions in right circumstances, and money from real estate sale and court case.